Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk -- Ignore unavailable to you. Want to Upgrade?

To: da_cheif™ who wrote (158062)	7/9/2021 11:21:12 PM
From: catflu2™	Respond to of 207899

cognitive dissonance. "a mind is like a parachute if it aint open it doesn't work"

To: da_cheif™ who wrote (158062)	7/10/2021 2:19:09 PM
From: Winfastorlose	6 Recommendations Recommended By D.Austin GROUND ZERO™ isopatch Mick Mørmøny roguedolphin and 1 more member Read Replies (1) \| Respond to of 207899

Leaked Confidentiality Agreement Shows Moderna, NIAID Filed Covid Vaccine Candidate in 2019 (so, way before anyone even supposedly knew there was a "Covid19", MRNA had filed with NIAID to recognize their candidate for the Covid19 vaccine. is "something rotten in the state of Denmark"? As Bannon always says, there are no conspiracy theories, but there are a lot of interesting coincidences. lol What is the vaccine really for and why are they now prepping to get people to take a "booster" every six months or so? Damn. That old guy isn't dead yet. Better try to sell him a booster shot.) STORY AT-A-GLANCE Moderna, together with the National Institute of Allergy and Infectious Diseases (NIAID), sent mRNA coronavirus vaccine candidates to the University of North Carolina at Chapel Hill on December 12, 2019 — raising significant red flags The providers agreed to transfer “mRNA coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna” to the university’s investigator and was signed by Ralph Baric Baric pioneered techniques for genetically manipulating coronaviruses, which became a major focus for research at the Wuhan Institute of Virology (WIV)Baric worked closely with WIV’s Shi Zhengli, Ph.D., on research using genetic engineering to create a “new bat SARS-like virus … that can jump directly from its bat hosts to humans” Serious questions need to be answered, including: Were Moderna, NIAID and Baric aware that COVID-19 was circulating in mid-December 2019, or did they have knowledge far before that such a vaccine would soon be in demand?